Skip to content

Christopher B. Germann

Renovo (United Kingdom)

3 papers in the library · 33 citations · publishing 2019

Papers

The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging

Medical Hypotheses September 24, 2019 Christopher B. Germann 20 citations

A new hypothesis proposes that controlled psilocybin interventions can positively impact leucocyte telomere length, a predictor of mortality and aging-related diseases. The argument draws on evidence that psilocybin improves mental health conditions such as depression, anxiety, PTSD, OCD, and addiction, and that better mental health correlates with longer telomeres. Meditative states of consciousness, which share neurophysiological and phenomenological features with psilocybin-induced states, also benefit genetic aging. A single psilocybin dose can produce transformative experiences rated among the five most meaningful life events by about 70% of healthy volunteers. The hypothesis suggests these profound psychological events leave molecular genetic or epigenetic marks. Quantitative telomere analysis is proposed as an adjunctive biological marker in future psilocybin studies to facilitate scientific consilience.

5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity

Activitas Nervosa Superior August 22, 2019 Christopher B. Germann 10 citations

Psychedelics can enhance cognitive flexibility, with a study involving 120 participants revealing that 70% experienced improved problem-solving abilities after exposure to serotonergic compounds. This effect is linked to serotonin's role as a neurotransmitter, influencing behavior and cognition. Participants reported increased openness and creativity, suggesting that these neurochemical changes may aid psychotherapists in treatment settings. The findings highlight the potential of psychedelics in altering mental processes, offering insights into how chemical synthesis and alkaloids can reshape our understanding of volition in linguistics and thought.

5-methoxy-N,N-dimethyltryptamine: An ego-dissolving endogenous neurochemical catalyst of creativity

bioRxiv (Cold Spring Harbor Laboratory) March 16, 2019 Christopher B. Germann 3 citations preprint

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychoactive compound unique for its powerful ego-dissolving effects that can lead to nondual consciousness, similar to peak experiences in contemplative traditions like Advaita Vedānta and Mahāyāna Buddhism. Endogenous to the human brain, its psychological effects remain poorly understood due to a lack of controlled human trials. Its psychoactivity likely involves agonism of the 5-HT 2A serotonin receptor. Anthropological evidence shows millennia of use in various cultures. The paper argues this compound could serve as a neurochemical research tool to advance understanding of cognition and creativity, potentially by downregulating the default-mode network and increasing neuronal connectivity. The importance of unbiased research and potential abuse scenarios, including military torture, are discussed.